Marking 20 years of the Access Campaign's work to secure access to affordable medicines, diagnostics and vaccines, including promoting their research and development, for people in MSF’s care and beyond.
![Villagers surrounded by water and stranded in a shrinking area of dry land[Photo: Nicola Flamigni/MSF]](https://msf.or.ke/sites/default/files/styles/444x232/public/msfimages/news/msf295696_medium.jpg?itok=NsLiI8sw "Villagers surrounded by water and stranded in a shrinking area of dry land[Photo: Nicola Flamigni/MSF]")
![$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine [Photo: MSF]](https://msf.or.ke/sites/default/files/styles/444x232/public/msfimages/news/msf230311_medium.jpg?itok=DhBafRyq "$262 million subsidy should not go to pharma giants Pfizer and GSK for pneumococcal vaccine [Photo: MSF]")
![Kingsley Makwale MSF clinician examining Aisha at Mbenje Health Centre [Photo: Isabel Corthier/MSF]](https://msf.or.ke/sites/default/files/styles/444x232/public/msfimages/news/msf295979_medium.jpg?itok=xgA2jzsX "Kingsley Makwale MSF clinician examining Aisha at Mbenje Health Centre [Photo: Isabel Corthier/MSF]")
Young people in South Africa have the fastest growing rates of HIV infection, with 39% of all new HIV infections occurring between ages 15 to 24 years. Yet young people have very low rates of HIV testing, and face challenges in accessing health services.
Noma is a little understood, rapidly progressing gangrenous infection of the mouth and face, associated with a high mortality rate. This preventable disease eats away rapidly tissue, leaving survivors with holes and facial disfigurements that cause them life-threatening impairments and provokes a social stigma.
